Both in Pharmaceuticals
Viatris vs Insmed
Over the past year VTRS returned +83.2% and INSM returned −39.8%; their daily moves had a correlation of -0.14.
VTRS +83.2% INSM −39.8%Growth of $1, one year, split-adjusted
| Metric | VTRS | INSM |
|---|---|---|
| Price | $19.22 | $110.00 |
| Market cap | $22.08B | $24.13B |
| Today | +1.59% | +5.32% |
| 1 month | +9.6% | +4.5% |
| 6 months | +20.5% | −19.8% |
| Year to date | +54.4% | −36.8% |
| 1 year | +82.5% | −40.9% |
| Revenue growth (YoY) | +4.9% | +268.4% |
| Gross margin | 38.8% | 85.1% |
| Net margin | −3.2% | −19.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 15.9× |
| Net cash | -$12.46B | $569.9M |
| Dividend yield | 2.50% | — |
| Volatility (60d) | 23.4% | 48.6% |
| Short % of float | 3.3% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).